TY - JOUR
T1 - 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D 4 Receptor
AU - Del Bello, Fabio
AU - Bonifazi, Alessandro
AU - Giorgioni, Gianfabio
AU - Cifani, Carlo
AU - Micioni Di Bonaventura, Maria Vittoria
AU - Petrelli, Riccardo
AU - Piergentili, Alessandro
AU - Fontana, Stefano
AU - Mammoli, Valerio
AU - Yano, Hideaki
AU - Matucci, Rosanna
AU - Vistoli, Giulio
AU - Quaglia, Wilma
N1 - Publisher Copyright:
© 2018 American Chemical Society.
PY - 2018/4/26
Y1 - 2018/4/26
N2 - In the present article, the M 1 mAChR bitopic agonist 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1, 1) has been demonstrated to show unexpected D 4 R selectivity over D 2 R and D 3 R and to behave as a D 4 R antagonist. To better understand the structural features required for the selective interaction with the D 4 R and to obtain compounds unable to activate mAChRs, the aliphatic butyl chain and the piperidine nucleus of 1 were modified, affording compounds 2-14. The 4-benzylpiperidine 9 and the 4-phenylpiperazine 12 showed high D 4 R affinity and selectivity not only over the other D 2 -like subtypes, but also over M 1 -M 5 mAChRs. Derivative 12 was also highly selective over some selected off-targets. This compound showed biased behavior, potently and partially activating G i protein and inhibiting β-arrestin2 recruitment in functional studies. Pharmacokinetic studies demonstrated that it was characterized by a relevant brain penetration. Therefore, 12 might be a useful tool to better clarify the role played by D 4 R in disorders in which this subtype is involved.
AB - In the present article, the M 1 mAChR bitopic agonist 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1, 1) has been demonstrated to show unexpected D 4 R selectivity over D 2 R and D 3 R and to behave as a D 4 R antagonist. To better understand the structural features required for the selective interaction with the D 4 R and to obtain compounds unable to activate mAChRs, the aliphatic butyl chain and the piperidine nucleus of 1 were modified, affording compounds 2-14. The 4-benzylpiperidine 9 and the 4-phenylpiperazine 12 showed high D 4 R affinity and selectivity not only over the other D 2 -like subtypes, but also over M 1 -M 5 mAChRs. Derivative 12 was also highly selective over some selected off-targets. This compound showed biased behavior, potently and partially activating G i protein and inhibiting β-arrestin2 recruitment in functional studies. Pharmacokinetic studies demonstrated that it was characterized by a relevant brain penetration. Therefore, 12 might be a useful tool to better clarify the role played by D 4 R in disorders in which this subtype is involved.
UR - http://www.scopus.com/inward/record.url?scp=85045991213&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045991213&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.8b00265
DO - 10.1021/acs.jmedchem.8b00265
M3 - Article
C2 - 29589445
AN - SCOPUS:85045991213
SN - 0022-2623
VL - 61
SP - 3712
EP - 3725
JO - Journal of medicinal chemistry
JF - Journal of medicinal chemistry
IS - 8
ER -